Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Amphastar Pharma Q2 Adj. EPS $0.85 Beats $0.76 Estimate, Sales $174.414M Beat $174.249M Estimate

Author: Benzinga Newsdesk | August 07, 2025 03:09pm
Amphastar Pharma (NASDAQ:AMPH) reported quarterly earnings of $0.85 per share which beat the analyst consensus estimate of $0.76 by 11.99 percent. This is a 9.57 percent decrease over earnings of $0.94 per share from the same period last year. The company reported quarterly sales of $174.414 million which beat the analyst consensus estimate of $174.249 million by 0.09 percent. This is a 4.38 percent decrease over sales of $182.394 million the same period last year.

Posted In: AMPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist